Security key
747324101
Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS)
CUSIP: 747324101
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 62,130,557
- Total 13F shares
- 26,713,589
- Share change
- -628,053
- Total reported value
- $59,287,871
- Price per share
- $2.22
- Number of holders
- 72
- Value change
- +$123,860
- Number of buys
- 25
- Number of sells
- 45
Report period
Q3 2025
Institutions
72
Top holders
10
PYXS full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Pyxis Oncology, Inc. SEC filings
Pyxis Oncology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 747324101
Recent filing periods:
Top shareholders of PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Lara Sullivan |
13D/G
3/4/5
|
Lara Sullivan, M.D. · President ,CEO & CMO, Director |
11%
|
7,543,007
|
$7,844,727 | +$955,040 | 31 Mar 2025 | |
| GordonMD Global Investments LP |
13D/G
|
— |
6.2%
|
3,834,740
|
$5,330,289 | $0 | 14 Jul 2025 | |
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
|
Millennium Management LLC |
4%
|
2,488,079
|
$2,587,602 | -$698,942 | 31 Mar 2025 | |
| BlackRock, Inc. |
13D/G
13F
|
Company |
1.5%
|
926,805
|
$2,192,635 | -$5,718,934 | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
13D/G
|
Company |
1.3%
from 13D/G
|
3,539,860
|
$3,893,846 | — | 30 Jun 2025 | |
| Ridgeback Capital Investments L.P. |
13D/G
|
— |
0.6%
|
359,231
|
$373,600 | $0 | 31 Dec 2024 | |
| PFIZER INC |
3/4/5
13F
|
10%+ Owner · Company |
11%
from 13F
|
7,032,770
|
$19,410,445 | — | 17 Mar 2023 | |
| Laurion Capital Management LP |
13F
|
Company |
5.8%
|
3,625,974
|
$3,988,571 | — | 30 Jun 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
4%
|
2,500,000
|
$2,750,000 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.5%
|
2,149,396
|
$2,364,336 | — | 30 Jun 2025 | |
| Palo Alto Investors LP |
13F
|
Company |
1.7%
|
1,037,421
|
$1,141,163 | — | 30 Jun 2025 | |
| Aberdeen Group plc |
13F
|
Company |
1.5%
|
913,045
|
$1,004,350 | — | 30 Jun 2025 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.88%
|
545,000
|
$599,500 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.82%
|
510,963
|
$562,250 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.67%
|
417,822
|
$459,604 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.64%
|
396,096
|
$435,706 | — | 30 Jun 2025 | |
| PIER 88 INVESTMENT PARTNERS LLC |
13F
|
Company |
0.59%
|
367,170
|
$403,887 | — | 30 Jun 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.54%
|
336,084
|
$369,692 | — | 30 Jun 2025 | |
| Decheng Capital LLC |
13F
|
Company |
0.53%
|
326,810
|
$359,491 | — | 30 Jun 2025 | |
| SCHULHOFF & CO INC |
13F
|
Company |
0.44%
|
275,000
|
$302,500 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.36%
|
224,274
|
$246,701 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.3%
|
186,055
|
$204,661 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.27%
|
165,044
|
$181,548 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.26%
|
160,174
|
$176,192 | — | 30 Jun 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.24%
|
147,771
|
$162,549 | — | 30 Jun 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.23%
|
142,295
|
$156,525 | — | 30 Jun 2025 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.21%
|
133,047
|
$146,352 | — | 30 Jun 2025 | |
| NewEdge Wealth, LLC |
13F
|
Company |
0.19%
|
116,006
|
$124,126 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.18%
|
114,359
|
$125,795 | — | 30 Jun 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.17%
|
103,063
|
$113,369 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.16%
|
102,216
|
$112,438 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
0.15%
|
94,846
|
$104,331 | — | 30 Jun 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.14%
|
86,763
|
$95,439 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.14%
|
86,328
|
$95,000 | — | 30 Jun 2025 | |
| Cable Car Capital, LP |
13F
|
Company |
0.1%
|
61,606
|
$67,767 | — | 30 Jun 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.1%
|
61,155
|
$67,000 | — | 30 Jun 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.08%
|
50,668
|
$55,000 | — | 30 Jun 2025 | |
| UNIVERSITY OF CHICAGO |
13F
|
Company |
0.08%
|
48,731
|
$53,604 | — | 30 Jun 2025 | |
| Jain Global LLC |
13F
|
Company |
0.08%
|
48,649
|
$53,514 | — | 30 Jun 2025 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.06%
|
40,000
|
$44,000 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.06%
|
36,516
|
$40,168 | — | 30 Jun 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.06%
|
36,380
|
$40,018 | — | 30 Jun 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.06%
|
35,428
|
$38,971 | — | 30 Jun 2025 | |
| Cetera Investment Advisers |
13F
|
Company |
0.05%
|
28,760
|
$31,636 | — | 30 Jun 2025 | |
| Catalyst Funds Management Pty Ltd |
13F
|
Company |
0.04%
|
23,200
|
$25,520 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.04%
|
22,069
|
$24,276 | — | 30 Jun 2025 | |
| Point72 Asia (Singapore) Pte. Ltd. |
13F
|
Company |
0.03%
|
19,228
|
$21,151 | — | 30 Jun 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.03%
|
18,942
|
$20,000 | — | 30 Jun 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.03%
|
17,721
|
$19,492 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
14,657
|
$16,123 | — | 30 Jun 2025 |
Institutional Holders of Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) as of Q3 2025
As of 30 Sep 2025,
Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) was held by
72 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,713,589 shares.
The largest 10 holders included
Pfizer Inc, Laurion Capital Management LP, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, Palo Alto Investors LP, MILLENNIUM MANAGEMENT LLC, STEMPOINT CAPITAL LP, BlackRock, Inc., and BANK OF AMERICA CORP /DE/.
This page lists
72
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
74
Q3 2025 holders
72
Holder diff
-2
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.